Aetna to Limit Enrollment in Medicare Plans in Ohio, Kentucky.(Knight Ridder/Tribune Business News)Powell, Cheryl
Medicare Medicaid We’re going to explore each option in the next few sections. Medical and Pharmacy Plans There are three different plan levels you can choose from when deciding an individual plan: Bronze, Silver, and Gold. The difference between each plan has to do with the monthly premium...
The target enrollment for the study is 700 participants who must have histologically confirmed stage IV or recurrent NSCLC, squamous or non-squamous histology, with no prior systemic anticancer therapy (including EGFR and ALK inhibitors), an ECOG performance status 0 or 1, and measurable disease. ...
Herndon et al (2023) performed a systematic review and meta-analysis to examine the occurrence of safety events following a switch to or from a biosimilar and its reference biologic in all identified controlled clinical studies that included a biosimilar approved by the FDA. The authors reviewed F...
This Clinical Policy Bulletin addresses bendamustine for commercial medical plans. For Medicare criteria, seeMedicare Part B Criteria. Note: Requires Precertification: Precertification of bendamustine (Belrapzo, Bendeka, Treanda, Vivimusta, and bendamustine) is required of all Aetna participating provider...
For Medicare criteria, see Medicare Part B Criteria.Note: Requires Precertification:Precertification of omalizumab (Xolair) is required of all Aetna participating providers and members in applicable plan designs. For precertification of omalizumab call (866) 752-7021 or fax (888) 267-3277. For ...
For Medicare criteria, see Medicare Part B Criteria. Note: Requires Precertification: Precertification of octreotide acetate (Sandostatin, Sandostatin LAR Depot), lanreotide (Somatuline or generic), pasireotide diaspartate (Signifor), and pasireotide pamoate (Signifor LAR) is required of all Aetna ...
Policy Scope of Policy This Clinical Policy Bulletin addresses pembrolizumab (Keytruda) for commercial medical plans. For Medicare criteria, seeMedicare Part B Criteria. Note: Requires Precertification: Precertification of pembrolizumab (Keytruda) is required of all Aetna participating providers and members...
This Clinical Policy Bulletin addresses aducanumab-avwa (Aduhelm) for commercial medical plans. For Medicare criteria, seeMedicare Part B Criteria. Note: Requires Precertification: Precertification of aducanumab-avwa (Aduhelm) is required of all Aetna participating providers and members in applicable pla...
The American Society of Cataract and Refractive Surgery (ASCRS) and American Society of Ophthalmic Administrators (ASOA) (Stodola, 2013) stated that “According to the ASCRS/ASOA policy, the allowable Medicare reimbursement for cataract surgery does not change according to the surgical methods used. ...